Have a personal or library account? Click to login
Comparative Effectiveness of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Randomized Pragmatic Clinical Trial Cover

Comparative Effectiveness of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Randomized Pragmatic Clinical Trial

Tremor and Other Hyperkinetic Movements
Volume 13 (2023): Issue 1
By: Dingwei Dai,  Joaquim Fernandes,  Han Kim and  Henriette Coetzer  
Open Access
|Oct 2023

References

  1. 1Kronenbuerger M, Konczak J, Ziegler W, Buderath P, Frank B, Coenen VA, et al. Balance and motor speech impairment in essential tremor. Cerebellum. 2009; 8(3): 389–398. DOI: 10.1007/s12311-009-0111-y
    Back to article
  2. 2Louis ED. Treatment of medically refractory essential tremor. N Engl J Med. 2016; 375(8): 792–793. DOI: 10.1056/NEJMe1606517
    Back to article
  3. 3Morgan S, Kellner S, Gutierrez J, Collins K, Rohl B, Migliore F, et al. The experience of essential tremor caregivers: burden and its correlates. Front Neurol. 2017; 8: 396. DOI: 10.3389/fneur.2017.00396
    Back to article
  4. 4Rao AK, Gilman A, Louis ED. Balance confidence and falls in nondemented essential tremor patients: the role of cognition. Arch Phys Med Rehabil. 2014; 95(10): 1832–1837. DOI: 10.1016/j.apmr.2014.04.001
    Back to article
  5. 5Song P, Zhang Y, Zha M, Yang Q, Ye X, Yi Q, et al. The global prevalence of essential tremor, with emphasis on age and sex: A meta-analysis. J Glob Health. 2021; 11: 04028. DOI: 10.7189/jogh.11.04028
    Back to article
  6. 6Louis ED, Ottman R. How many people in the USA have essential tremor? Deriving a population estimate based on epidemiological data. Tremor Hyperkinetic Mov. 2014; 4: 259. DOI: 10.5334/tohm.198
    Back to article
  7. 7Dai D, Samiian A, Fernandes J, Coetzer H. Multiple comorbidities, psychiatric disorders, healthcare resource utilization and costs among adults with essential tremor: a retrospective observational study in a large US commercially insured and Medicare Advantage population. J Health Econ Outcomes Res. 2022; 9(2): 37–46. DOI: 10.36469/001c.37307
    Back to article
  8. 8Vetterick C, Lyons KE, Matthews LG, Pendal R, Ravina B. The hidden burden of disease and treatment experiences of patients with essential tremor: a retrospective claims data analysis. Adv Ther. 2022; 39(12): 5546–5567. DOI: 10.1007/s12325-022-02318-8
    Back to article
  9. 9Bhidayasiri R. Differential diagnosis of common tremor syndromes. Postgrad Med J. 2005; 81(962): 756–762. DOI: 10.1136/pgmj.2005.032979
    Back to article
  10. 10Gupta HV, Pahwa R, Dowell P, Khosla S, Lyons KE. Exploring essential tremor: Results from a large online survey. Clin Park Relat Disord. 2021; 5: 100101. DOI: 10.1016/j.prdoa.2021.100101
    Back to article
  11. 11Louis ED. Treatment of Essential Tremor: Are there Issues We are Overlooking? Front Neurol. 2012; 2: 91. DOI: 10.3389/fneur.2011.00091
    Back to article
  12. 12Ferreira JJ, Mestre TA, Lyons KE, Benito-León J, Tan E, Abbruzzese G, et al. MDS evidence-based review of treatments for essential tremor. Mov Disord. 2019; 34(7): 950–958. DOI: 10.1002/mds.27700
    Back to article
  13. 13Jung IH, Chang KW, Park SH, Chang WS, Jung HH, Chang JW. Complications after deep brain stimulation: a 21-year experience in 426 patients. Front Aging Neurosci. 2022; 14: 819730. DOI: 10.3389/fnagi.2022.819730
    Back to article
  14. 14Ravikumar VK, Parker JJ, Hornbeck TS, Santini VE, Pauly KB, Wintermark M, et al. Cost-effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor. Mov Disord. 2017; 32(8): 1165–1173. DOI: 10.1002/mds.26997
    Back to article
  15. 15Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, et al. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson’s disease. Mov Disord. 2018; 33(8): 1248–1266. DOI: 10.1002/mds.27372
    Back to article
  16. 16Lyons KE, OTT KR, Shill H. Essential Tremor Guidelines Advisory – Essential Tremor Advisory – IETF [Internet]. [cited 2023 Jun 30]. Available from: https://eguideline.guidelinecentral.com/i/1380755-essential-tremor-advisory-ietf/0?.
    Back to article
  17. 17U.S. Food & Drug Administration. 510(k) Premarket Notification for Cala Trio (K203288) [Internet]. 2021 [cited 2023 Jun 30]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K203288.
    Back to article
  18. 18U.S. Food & Drug Administration. De Novo Classification Request for Cala ONE (DEN170027) [Internet]. 2017 [cited 2023 Jun 30]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K203288.
    Back to article
  19. 19Pahwa R, Dhall R, Ostrem J, Gwinn R, Lyons K, Ro S, et al. An acute randomized controlled trial of noninvasive peripheral nerve stimulation in essential tremor. Neuromodulation. 2019; 22(5): 537–545. DOI: 10.1111/ner.12930
    Back to article
  20. 20Isaacson SH, Peckham E, Tse W, Waln O, Way C, Petrossian MT, et al. Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor. Tremor Hyperkinetic Mov. 2020; 10: 29. DOI: 10.5334/tohm.59
    Back to article
  21. 21Yu JY, Rajagopal A, Syrkin-Nikolau J, Shin S, Rosenbluth KH, Khosla D, et al. Transcutaneous Afferent Patterned Stimulation Therapy Reduces Hand Tremor for One Hour in Essential Tremor Patients. Front Neurosci. 2020; 14: 530300. DOI: 10.3389/fnins.2020.530300
    Back to article
  22. 22Brillman S, Colletta K, Borucki S, Lin PT, Waln O, Petrossian M, et al. Real-World Evidence of Transcutaneous Afferent Patterned Stimulation for Essential Tremor. Tremor Hyperkinetic Mov. 2022; 12(1): 27. DOI: 10.5334/tohm.715
    Back to article
  23. 23Lin PT, Ross EK, Chidester P, Rosenbluth KH, Hamner SR, Wong SH, et al. Noninvasive neuromodulation in essential tremor demonstrates relief in a sham-controlled pilot trial: Neuromodulation for Essential Tremor. Mov Disord. 2018; 33(7): 1182–1183. DOI: 10.1002/mds.27350
    Back to article
  24. 24Wagle Shukla A. Rationale and Evidence for Peripheral Nerve Stimulation for Treating Essential Tremor. Tremor Hyperkinetic Mov. 2022; 12: 20. DOI: 10.5334/tohm.685
    Back to article
  25. 25Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother. 2010; 1(2): 100–107. DOI: 10.4103/0976-500X.72352
    Back to article
  26. 26Dai D, Sharma A, Alvarez PJ, Woods SD. Multiple comorbid conditions and healthcare resource utilization among adult patients with hyperkalemia: A retrospective observational cohort study using association rule mining. J Multimorb Comorbidity. 2022; 12: 26335565221098830. DOI: 10.1177/26335565221098832
    Back to article
  27. 27Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008; 61(12): 1234–1240. DOI: 10.1016/j.jclinepi.2008.01.006
    Back to article
  28. 28Bain PG, Findley LJ, Atchison P, Behari M, Vidailhet M, Gresty M, et al. Assessing tremor severity. J Neurol Neurosurg Psychiatry. 1993; 56(8): 868–873. DOI: 10.1136/jnnp.56.8.868
    Back to article
  29. 29Pulliam CL, Eichenseer SR, Goetz CG, Waln O, Hunter CB, Jankovic J, et al. Continuous in-home monitoring of essential tremor. Parkinsonism Relat Disord. 2014; 20(1): 37–40. DOI: 10.1016/j.parkreldis.2013.09.009
    Back to article
  30. 30Zheng X, Vieira Campos A, Ordieres-Meré J, Balseiro J, Labrador Marcos S, Aladro Y. Continuous Monitoring of Essential Tremor Using a Portable System Based on Smartwatch. Front Neurol. 2017; 8: 96. DOI: 10.3389/fneur.2017.00096
    Back to article
  31. 31Elble RJ. Physiologic and essential tremor. Neurology. 1986; 36(2): 225–225. DOI: 10.1212/WNL.36.2.225
    Back to article
  32. 32Heldman DA, Jankovic J, Vaillancourt DE, Prodoehl J, Elble RJ, Giuffrida JP. Essential tremor quantification during activities of daily living. Parkinsonism Relat Disord. 2011; 17(7): 537–542. DOI: 10.1016/j.parkreldis.2011.04.017
    Back to article
  33. 33McGurrin P, McNames J, Haubenberger D, Hallett M. Continuous Monitoring of Essential Tremor: Standards and Challenges. Movement Disord Clin Pract. 2022; 9(8): 1094–1098. DOI: 10.1002/mdc3.13558
    Back to article
  34. 34Lu C, Khosla D, Kent A, Bronte-Stewart HM, Rosenbluth KH. Transcutaneous Afferent Patterned Stimulation for Essential Tremor: Real-World Evidence with Long Term Follow-Up. Tremor Other Hyperkinet Mov (N Y). 2023; 13(1): 29. DOI: 10.5334/tohm.775
    Back to article
  35. 35Pascual-Valdunciel A, Rajagopal A, Pons JL, Delp S. Non-invasive electrical stimulation of peripheral nerves for the management of tremor. J Neurol Sci. 2022; 435: 120195. DOI: 10.1016/j.jns.2022.120195
    Back to article
  36. 36Munder T, Brütsch O, Leonhart R, Gerger H, Barth J. Researcher allegiance in psychotherapy outcome research: an overview of reviews. Clin Psychol Rev. 2013; 33(4): 501–511. DOI: 10.1016/j.cpr.2013.02.002
    Back to article
  37. 37James KE, Bloch DA, Lee KK, Kraemer HC, Fuller RK. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation—a VA cooperative study. Stat Med. 1996; 15(13): 1421–1434. DOI: 10.1002/(SICI)1097-0258(19960715)15:13<;1421::AID-SIM266>3.0.CO;2-H
    Back to article
  38. 38Zesiewicz TA, Chari A, Jahan I, Miller AM, Sullivan KL. Overview of essential tremor. Neuropsychiatr Dis Treat. 2010; 6: 401–408. DOI: 10.2147/NDT.S4795
    Back to article
  39. 39Deuschl G, Raethjen J, Hellriegel H, Elble R. Treatment of patients with essential tremor. Lancet Neurol. 2011; 10(2): 148–161. DOI: 10.1016/S1474-4422(10)70322-7
    Back to article
  40. 40Sharma S, Pandey S. Treatment of essential tremor: current status. Postgrad Med J. 2020; 96(1132): 84–93. DOI: 10.1136/postgradmedj-2019-136647
    Back to article
  41. 41Ondo WG. Current and Emerging Treatments of Essential Tremor. Neurol Clin. 2020; 38(2): 309–323. DOI: 10.1016/j.ncl.2020.01.002
    Back to article
  42. 42Davis NJ, Gold E, Pascual-Leone A, Bracewell RM. Challenges of proper placebo control for non-invasive brain stimulation in clinical and experimental applications. Eur J Neurosci. 2013; 38(7): 2973–2977. DOI: 10.1111/ejn.12307
    Back to article
  43. 43Rajput AH, Rajput A. Medical Treatment of Essential Tremor. J Cent Nerv Syst Dis. 2014; 6: 29–39. DOI: 10.4137/JCNSD.S13570
    Back to article
DOI: https://doi.org/10.5334/tohm.798 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Jul 8, 2023
Accepted on: Oct 5, 2023
Published on: Oct 16, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
transcutaneous afferent patterned stimulation,
essential tremor,
peripheral neuromodulation,
hand tremor,
activities of daily living,
randomized pragmatic clinical trial

© 2023 Dingwei Dai, Joaquim Fernandes, Han Kim, Henriette Coetzer, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 13 (2023): Issue 1Next article